American Pacific Rim Commerce Group (OTC:APRM.OB), building on Revenue Guidance issued on Monday, November 1, 2010, announced further guidance related to its proprietary ecommerce platform to be named mymyJ and the underlying methodology for its development, testing and revenue drivers. In determining the product categories, the Company relied upon published research, internal studies and noted experts. Beta-testing of mymyJ platform is on-going and the Company anticipates launching its proprietary technology, which translates English to Mandarin and Cantonese dialects seamlessly, so Small and Medium U.S. (SME) manufacturers and producers of goods products and services can cost effectively and efficiently communicate, market and sell their goods to willing buyers in China and Hong Kong.
Stated Raymond Talarico, President, "Accordingly, given our in-depth research and analysis of the market, and where the Chinese consumers are spending their discretionary income, we have developed a focused product category lineup from which we will launch mymyJ and initiate sales to Asia." Further stated Talarico, "Given the Chinese consumers proclivity for allocating their on-line purchases in this manner, our next phase will be to finalize contracts with those quintessential U.S. brands, which strengthen our broad initiative of being the first mover in the direct-to-consumer market serving the Chinese consumer with products made in the U.S.A."
Mr. Talarico is a visionary in business conception and corporate design and has incubated numerous projects from a one sentence business concept, to revenue producing operations and ultimately to an exchange listing creating a publically traded corporate currency.
Prior to joining American Pacific Rim Commerce Group, Mr. Talarico was founder, CEO and Chairman of MEDirect Latino Inc., at his departure MEDirect was the largest distributor of diagnostic testing supplies to the Hispanic Medicare eligible market. Mr. Talarico developed the original business concept of serving a niche market (Spanish Medicare eligible diabetics) audience by marketing to them in their native language (Spanish). Developing this niche required Mr. Talarico to build MEDirect in a foreign language to service the eligible clients.
Overcoming the language barrier was key to the development of the company, as was the marketing strategy to reach the customer. Mr. Talarico developed a proprietary algorithm to amalgamate information from the Departments of Treasury, Internal Revenue Service and the Center for Medicare & Medicaid which developed geographical targets for media efforts.
The executive team he assembled was fully bi-lingual and was responsible for Procedures and Protocols for billing the U.S. Government earning the gold seal of approval, accreditation from The Joint Commission, National Quality Approval Rating. In addition, Mr. Talarico was responsible for oversight and management of operational, budgetary and corporate matters, development of strategic planning and ensuring sales goals were met, interfacing with COO, CFO and department heads to establish cohesive direction. Mr. Talarico was instrumental in the development, planning and logistics for the manufacturing of the Company's proprietary line of diabetes testing supplies, manufactured for the Company in China. Mr. Talarico met with and completed the process which earned the company's products FDA approval for distribution in the United States and approval for reimbursement for the products by Medicare and Medicaid.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.(OTCPK:CRWE) has received five thousand dollars in cash from a third party (Act Group) for one (1) day of advertising for American Pacific Rim Commerce Group (OTC:APRM).